InspireMD, Inc. (NSPR)
Data as of , from SEC Form 4 filings.
See up to 3 months of NSPR. The 7-day demo opens the 1M and 3M ranges and puts NSPR on your watchlist.
Start 7-day demoLatest NSPR insider trades
Paul Stuka - DirectorOpen-market purchase$18K
Shane Thomas Gleason - OfficerOpen-market sale
About InspireMD, Inc. (NSPR)
The SEC lists InspireMD, Inc. under CIK 0001433607, in surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
NSPR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Other acquisition / disposition | 12 | 538,120 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NSPR insider transactions (Form 4)
1439 Form 4 filings on record, the earliest from Jun 25, 2025, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Thomas J. Kester - Director | Grant or award | Common Stock | 37,815 | $0.00 | - | |
| Thomas J. Kester - Director | Grant or award | Options to purchase common stock (right to buy) | 19,041 | $0.00 | - | |
 Gary S. Roubin - Director | Open-market purchase | Common Stock | 41,322 | $2.42 | $100K | |
| Thomas J. Kester - Director | Open-market purchase | Common Stock | 30,991 | $2.42 | $75K | |
 Marvin Slosman - Officer | Open-market purchase | Common Stock | 10,330 | $2.42 | $25K | |
| Paul Stuka - Director | Open-market purchase | Common Stock | 20,661 | $2.42 | $50K | |
| Thomas J. Kester - Director | Other | Series I Warrant (right to buy) | 30,624 | $0.00 | - | |
| Thomas J. Kester - Director | Other | Common Stock | 30,624 | $1.38 | $42K | |
| Paul Stuka - Director | Other | Common Stock | 87,500 | $1.38 | $121K | |
| Paul Stuka - Director | Other | Series I Warrant (right to buy) | 87,500 | $0.00 | - | |
 Michael Berman - Director | Other | Common Stock | 61,248 | $1.38 | $85K | |
| Michael Berman - Director | Other | Series I Warrant (right to buy) | 61,248 | $0.00 | - | |
| Gary S. Roubin - Director | Other | Common Stock | 30,624 | $1.38 | $42K | |
| Gary S. Roubin - Director | Other | Series I Warrant (right to buy) | 30,624 | $0.00 | - |
NSPR insider trading FAQ
What is the latest insider trade for NSPR?
InspireMD, Inc. (NSPR) had 3 insider filings in the last 90 days, with the most recent on 2026-09-23. The full record for NSPR runs to 39 Form 4 filings, the earliest from 2025-06-25. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NSPR stock?
No insider purchases of NSPR were filed in the last 90 days. 22 purchases are on record for this company.
How many insiders are selling NSPR stock?
No insider sales of NSPR were filed in the last 90 days. 24 sales are on record for this company.
Where can I see NSPR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NSPR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Michael Berman view on EDGAR
- - Gary S. Roubin view on EDGAR
- - Paul Stuka view on EDGAR
- - Paul Stuka view on EDGAR
- - Shane Thomas Gleason view on EDGAR
- - Paul Stuka view on EDGAR
- - Marvin Slosman view on EDGAR
- - Paul Stuka view on EDGAR
- - Paul Stuka view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where NSPR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NSPR with a 7-day demo
- NSPR on your watchlist
- Every NSPR Form 4 filing on record
- Up to 3 months of NSPR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
